Article

High-resolution, wavefront-guided treatment aids night vision

San Diego-Wavefront-guided treatments seem to improve night-vision disturbances caused by LASIK. Patients with severe higher-order aberrations after the initial refractive procedure benefitted from treatment driven by the Wavefront Aberration Supported Corneal Ablation (WASCA) aberrometer and the MEL-80 excimer laser driven by the CRS-Master software platform (all from Carl Zeiss Meditec AG).

San Diego-Wavefront-guided treatments seem to improve night-vision disturbances caused by LASIK. Patients with severe higher-order aberrations after the initial refractive procedure benefitted from treatment driven by the Wavefront Aberration Supported Corneal Ablation (WASCA) aberrometer and the MEL-80 excimer laser driven by the CRS-Master software platform (all from Carl Zeiss Meditec AG).

During the annual meeting of the American Society of Cataract and Refractive Surgery, he spoke about the accuracy of a vision-correction system that included the WASCA aberrometer, the CRS-Master, the MEL-80 excimer laser, and the Artemis 2 (Ultralink LCC), a very high-frequency (VHF) digital ultrasound arc scanner.

"The WASCA aberrometer is the highest-resolution wavefront sensor available," he said. "It provides a higher dynamic range, higher (degree of) accuracy, and higher (degree of) reproducibility than other competing aberrometers.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.